Licenses gas-fermentation technology and provides plant studies, engineering and biocatalysts to industrial customers; also sells ethanol and other chemical building blocks.
10-K for FY2025, filed Mar 31, 2026The Company recognizes revenue from exchange transactions in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”) and…View ↗
The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction…View ↗
The Company licenses intellectual property to generate recurring revenue, in the case of running royalties, or one-time revenue, in the…View ↗
Today, LanzaTech technology is used by customers to produce CarbonSmart ethanol, which can be used directly or further converted into…View ↗
Biorefining customers pay for plant studies and engineering as work is done, and for technology licenses through one-time fees or royalties tied to plant sales or use. Research payments are due at milestones or report submission; CarbonSmart customers buy ethanol and derivatives, with sales counted when products are delivered under agreed shipping terms.
10-K for FY2025, filed Mar 31, 2026The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction…View ↗
The Company licenses intellectual property to generate recurring revenue, in the case of running royalties, or one-time revenue, in the…View ↗
Revenue is not recognized in advance of customer acceptance of a milestone when such acceptance is contractually required. Payments for R&D…View ↗
The Company purchases ethanol from the customers who have deployed the Company’s proprietary technologies in their biorefining plants and…View ↗
10-K for FY2025, filed Mar 31, 2026
FY2025 revenue by product or service ↗$55.8M
10-K for FY2025, filed Mar 31, 2026
$55.8M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Biorefining revenue
Licensed
10-K for FY2025, filed Mar 31, 2026 |
65%
FY2022: 57%
|
Biorefining revenue, FY2025
$36M Sources
|
Licensed |
|
Joint development and contract research revenue
Sold outright
|
9.3%
FY2022: 32%
|
Joint development and contract research revenue, FY2025
$5.2M Sources
|
Sold outright |
|
CarbonSmart product
Sold outright
10-K for FY2025, filed Mar 31, 2026 |
26%
FY2022: 11%
|
CarbonSmart product, FY2025
$14.6M Sources
|
Sold outright |
Industrial customers build and operate plants using LanzaTech's technology; the company also sells ethanol and derivatives to end customers and performs research for commercial and government customers.
10-K for FY2025, filed Mar 31, 2026Our scalable carbon capture and utilization (“CCU”) technology empowers industrial, municipal, and agricultural partners around the world…View ↗
LanzaTech employs a licensing business model whereby our customers build, own and operate facilities that use our technology, and in…View ↗
The Company performs R&D services related to novel technologies and development of biocatalysts for commercial applications, mainly to…View ↗
The Company purchases ethanol from the customers who have deployed the Company’s proprietary technologies in their biorefining plants and…View ↗
10-K for FY2025, filed Mar 31, 2026
For the fiscal year ended December 31, 2025, our largest contracting entity accounted for 37% of our revenue, as compared to 25% for the…View ↗
No. It lost $49M in FY2025.
10-Q for Q3 FY2026, filed Nov 16, 2026
−$178MView ↗
10-Q for Q3 FY2026, filed Nov 16, 2026
Open tableView ↗
8-K, filed Apr 16, 2026
On April 10, 2026, upon the recommendation and approval of the Audit Committee of the Board of Directors (the “Audit Committee”), the Board…View ↗
More ownership in biorefining
The earlier report centered on licensing and selective co-development with partner-owned plants; the latest adds greater ownership and operating roles in biorefining.
10-K for Q1 FY2022, filed Mar 29, 2023 10-K for FY2025, filed Mar 31, 2026We aim to maximize revenue through the selective deployment of both our licensing and co-development models. Our licensing model focuses on…View ↗
LanzaTech employs a licensing business model whereby our customers build, own and operate facilities that use our technology, and in…View ↗
Protein as a primary product
The older report described protein-rich used microorganisms as animal feed; the latest also describes single-cell protein as a primary product from gas fermentation.
10-K for Q1 FY2022, filed Mar 29, 2023 10-K for FY2025, filed Mar 31, 2026Our low carbon ethanol is being produced at commercial scale at three separate locations in China, with production of over 54 million…View ↗
We are a nature-based carbon refining company that develops technology to transform waste carbon into the chemical building blocks for…View ↗
Loading...